1Lee SM,Suen Y,Qian J,et al.The regulation and biological activity of interleukin 12.Leuk Lymphoma,1998,29:427-438.
2Zagozdzon R,Giermasz A,Golab J,et al.The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production.Cancer Lett,1999,147:1-2,67-75.
5Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making [ J ]. J Clin Oncol, 2005 ; 23 : 7594 - 7603
6Mitelman F(ed). ISCN (1995) :An International System for Human Cytogenetic Nomenclature [ M ]. Basel, Switzerland Karger, 1995
7Babicka L, Ransdorfova S, Brezinova J, et al. Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH[ J]. Leuk Res,2007 ;31:39 -47
8Oren H, Yuksel E, Yilmaz S, et al. Poor clinical course in a child with myelodysplastic syndrome and del( 13 )(q14q22) [J]. Cancer Genet Cytogenet,2005 ; 163:74 - 76
9Trost D, Hildebrandt B, Beier M, et al. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia [ J ]. Cancer Genet Cytogenet,2006 ; 165:51 - 63
10Epstein AL, chen FM,Toylor CR; A novel method for the detection of necrotic lesions in human cancers [ J ]. Cancer Res, 1988 ;48:5842
